FindTrial
Sign In

Placebo plus immunosuppression

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Marmara University

Conditions

Behcet DiseaseBehcet Disease and Vascular InvolvementDeep Venous ThrombosesGraft Function/SurvivalKidney TransplantKidney Transplant RecipientPost Thrombotic Syndromede Novo HLA Antibodies Development

Phase 2

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
CompletedNCT00307125
National Institute of Allergy and Infectious Diseases (NIAID)de Novo HLA Antibodies Development, Graft Function/Survival, Kidney Transplant +1
Start: 2006-03-31End: 2012-12-31Updated: 2015-03-23

Phase 3

Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease
Not yet recruitingNCT06925698
Marmara UniversityBehcet Disease, Behcet Disease and Vascular Involvement, Deep Venous Thromboses +1
Start: 2025-04-30End: 2028-04-01Target: 110Updated: 2025-04-13

Related Papers

Discrepant serological assays for<i>Pneumococcus</i>in renal transplant recipients - a prospective study
Transplant International2017-03-279 citations